Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence.

Hu FB, Grodstein F.

Am J Cardiol. 2002 Jul 3;90(1A):26F-29F. Review.

PMID:
12106637
2.

Comparative cardiovascular effects of different progestins in menopause.

Rosano GM, Fini M.

Int J Fertil Womens Med. 2001 Sep-Oct;46(5):248-56. Review.

PMID:
11720197
3.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
4.

Postmenopausal hormones and coronary artery disease: potential benefits and risks.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:21-6. Review.

PMID:
17882668
5.

Recent concerns surrounding HRT.

Armitage M, Nooney J, Evans S.

Clin Endocrinol (Oxf). 2003 Aug;59(2):145-55. Review.

PMID:
12864790
6.

A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.

Psaty BM, Heckbert SR, Atkins D, Siscovick DS, Koepsell TD, Wahl PW, Longstreth WT Jr, Weiss NS, Wagner EH, Prentice R, et al.

Arch Intern Med. 1993 Jun 28;153(12):1421-7. Review.

PMID:
8512434
7.
8.
9.

The risk of stroke in postmenopausal women receiving hormonal therapy.

Lobo RA.

Climacteric. 2009;12 Suppl 1:81-5. Review.

PMID:
19811248
10.

Hormone therapy and thromboembolic disease.

Battaglioli T, Martinelli I.

Curr Opin Hematol. 2007 Sep;14(5):488-93. Review.

PMID:
17934355
11.

[Menopausal hormone therapy and cardiovascular disease].

Wenger NK.

Rev Esp Cardiol. 2006 Oct;59(10):1058-69. Review. Spanish.

12.

Reproductive hormones and cardiovascular disease mechanism of action and clinical implications.

Wagner JD, Kaplan JR, Burkman RT.

Obstet Gynecol Clin North Am. 2002 Sep;29(3):475-93. Review.

PMID:
12353669
13.
14.

Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy.

Rosano GM, Fini M.

Cardiol Rev. 2002 Jan-Feb;10(1):51-60. Review.

PMID:
11790270
15.

A comparative review of the risks and benefits of hormone replacement therapy regimens.

Warren MP.

Am J Obstet Gynecol. 2004 Apr;190(4):1141-67. Review.

PMID:
15118656
16.

Estrogen and progestogen therapy in postmenopausal women.

Practice Committee of American Society for Reproductive Medicine.

Fertil Steril. 2008 Nov;90(5 Suppl):S88-102. doi: 10.1016/j.fertnstert.2008.08.091. Review.

PMID:
19007655
17.

[Hormone therapy and risk for venous thromboembolism in postmenopausal women].

Lacut K, Oger E.

Rev Prat. 2005 Feb 28;55(4):389-92. Review. French.

PMID:
15828617
18.

Clinical cardiovascular studies of hormone replacement therapy.

Collins P.

Am J Cardiol. 2002 Jul 3;90(1A):30F-34F. Review.

PMID:
12106638
19.

Where are we with postmenopausal hormone therapy in 2005?

Lam PM, Chung TK, Haines C.

Gynecol Endocrinol. 2005 Nov;21(5):248-56. Review.

PMID:
16373243
20.

Estrogens are indicated for the prevention of coronary artery disease: a debate for estrogen.

Leiter LA.

Can J Cardiol. 2000 Aug;16 Suppl E:13E-16E. Review.

PMID:
10906619
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk